Skip to main content
. 2010 Apr 20;7(2):72–81. doi: 10.7150/ijms.7.72

Figure 1.

Figure 1

Clinical course of a CML patient treated with WT1 peptide vaccination. Figure shows copy numbers of bcr-abl transcripts/μg RNA extracted from PB-nucleated cells, frequency of WT1/MHC tetramer+CD8+ cells in 106 PB-CD8+ cells and percentage of PB-low frequent immunocompetent cells such as pDCs, mDC1s, γδT cells and Treg cells.